Beximco Pharmaceuticals PLC. - 存託憑證(普通股) - 資產負債表 (Quarterly)

Beximco Pharmaceuticals PLC. - 存託憑證(普通股)
GB ˙ AIM ˙ US0885792061
£42.50 0.00 (0.00%)
2026-01-02
分享價格
資產負債表 (Quarterly)

Beximco Pharmaceuticals PLC. - 存託憑證(普通股)資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
現金 675 545 1,181 589 1,169 873 1,247 984 1,136 944 1,096 1,160 854 859 1,655
改變 (%) -19.28 116.54 -50.11 98.40 -25.33 42.84 -21.08 15.44 -16.89 16.10 5.90 -26.40 0.62 92.62
流動資產 13,771 13,985 17,392 17,852 18,419 19,630 21,275 20,853 20,876 20,942 22,144 21,814 20,818 22,534 24,632
改變 (%) 1.55 24.37 2.65 3.18 6.57 8.38 -1.98 0.11 0.32 5.74 -1.49 -4.57 8.24 9.31
資產 52,246 57,759 65,080 65,153 66,148 67,475 69,314 68,847 69,157 69,352 70,627 70,223 69,344 70,898 73,802
改變 (%) 10.55 12.68 0.11 1.53 2.01 2.73 -0.67 0.45 0.28 1.84 -0.57 -1.25 2.24 4.10
負債 14,881 18,910 22,284 21,311 21,512 21,429 23,590 22,215 21,537 20,164 21,583 19,813 17,441 17,303 20,173
改變 (%) 27.07 17.84 -4.37 0.95 -0.39 10.09 -5.83 -3.05 -6.37 7.04 -8.20 -11.97 -0.79 16.59
公平 37,365 38,849 42,796 43,842 44,636 46,046 45,724 46,632 47,620 49,187 49,044 50,411 51,903 53,595 53,629
改變 (%) 3.97 10.16 2.44 1.81 3.16 -0.70 1.99 2.12 3.29 -0.29 2.79 2.96 3.26 0.06
負債和股本 52,246 57,759 65,080 65,153 66,148 67,475 69,314 68,847 69,157 69,352 70,627 70,223 69,344 70,898 73,802
改變 (%) 10.55 12.68 0.11 1.53 2.01 2.73 -0.67 0.45 0.28 1.84 -0.57 -1.25 2.24 4.10

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:R2WA €0.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista